Full text loading...
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Dosimetric characteristics of the DRAXIMAGE model LS-1 I-125 interstitial brachytherapy source design: A Monte Carlo investigation
1.J. F. Williamson et al., “Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources,” Med. Phys. 25, 2269–2270 (1998).
2.R. Nath et al., “Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43,” Med. Phys. 22, 209–234 (1995).
3.H. Perera et al., “Dosimetric characteristics, Air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source,” Int. J. Radiat. Oncol., Biol., Phys. 28, 953–971 (1994).
4.M. J. Rivard, “Monte Carlo calculations of AAPM Task Group No. 43 dosimetry parameters for the MED3631-A/M source,” Med. Phys. (in press).
5.J. F. Williamson, “Monte Carlo simulation of photon transport phenomena,” in Monte Carlo Simulation in the Radiological Sciences, edited by R. L. Morin (CRC, Boca Raton, FL, 1988), pp. 53–102.
6.R. K. Das et al., “Validation of Monte Carlo dose calculations near I-125 brachytherapy sources in the presence of bounded tissue heterogeneities,” Int. J. Radiat. Oncol., Biol., Phys. 38, 843–853 (1995).
7.R. K. Das et al., “Accuracy of Monte Carlo photon transport simulation in characterizing brachytherapy dosimeter energy response artifacts,” Phys. Med. Biol. 41, 995–1006 (1996).
8.J. F. Williamson, “Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds,” Med. Phys. 18, 776–786 (1991).
9.J. F. Williamson, H. Perera, and Z. Li, “Comparison of calculated and measured heterogeneity correction factors for and brachytherapy sources near localized heterogeneities,” Med. Phys. 20, 209–222 (1993).
10.Z. Li and J. F. Williamson, “Volume-based geometric modeling for radiation transport calculations,” Med. Phys. 19, 667–677 (1992).
11.Z. Li, J. F. Williamson, and H. Perera, “Monte Carlo calculation of kerma to a point in the vicinity of media interfaces,” Phys. Med. Biol. 38, 1825–1840 (1993).
12.J. F. Williamson and A. S. Meigooni, “Quantitative dosimetry methods for brachytherapy,” in Brachytherapy Physics, edited by J. F. Williamson, B. R. Thomadsen, and R. Nath (Medical Physics Publishing, Madison, WI, 1995), pp. 87–134.
13.J. F. Williamson, “Monte Carlo evaluation of kerma at a point for photon transport problems,” Med. Phys. 14, 567–576 (1987).
14.E. F. Plechaty, D. E. Cullen, and R. J. Howerton, “Tables and graphs of photo-interaction cross sections from 0.1 keV to 100 MeV derived from the LLL Evaluated-Nuclear-Data Library,” Report No. UCRL-50400, Vol. 6, Rev. 2, Lawrence Livermore Laboratory, Livermore, CA, 1978.
15.J. F. Williamson, “Monte Carlo evaluation of specific dose constants in water seeds,” Med. Phys. 15, 686–694 (1988).
16.RSIC, “HUGO-VI: Photon interaction data in ENDF/B-VI Format,” RSIC Data Library, Report No. DLC-146, Radiation Shielding Information Center, Oak Ridge National Laboratory, Oak Ridge, TN, 1989.
17.J. H. Hubbell and S. M. Seltzer, “Tables of x-ray mass attenuation coefficients and mass energy-absorption coefficients 1 keV to 20 MeV for elements to 92 and 48 additional substances of dosimetric interest,” Report No. NISTIR 5632, National Institutes of Standards and Technology, 1995.
18.J. F. Williamson, F. C. Deibel, and R. L. Morin, “The significance of electron binding corrections in photon transport calculations,” Phys. Med. Biol. 29, 404–414 (1986).
19.L. R. M. Morin, “Molecular form factors and photon coherent scattering cross sections of water,” J. Phys. Chem. Ref. Data 11, 1091–1098 (1982).
20.NUDAT/PCNUDAT Program for Nuclear Data, 9 March 2001, National Nuclear Data Center, Brookhaven National Laboratory, Upton, NY, http://www.nndc.bnl.gov/nndc/nudat/.
21.R. K. Valicenti et al., “Experimental validation of Monte Carlo dose-calculations about a high-intensity Ir-192 source for pulsed dose-rate brachytherapy,” Med. Phys. 22, 821–830 (1995).
22.J. F. Williamson and Z. Li, “Monte Carlo aided dosimetry of the microselectron pulsed and high dose-rate sources,” Med. Phys. 22, 809–819 (1995).
23.S. M. Seltzer and P. J. Lamperti, “Status of NIST primary standards for and therapy seeds based on the wide-angle free-air chamber (WAFAC): Proceedings of a CIRMS Workshop,” National Institute of Standards and Technology, Gaithersburg, MD, 1999.
24.R. Loevinger, “Wide-angle free-air chamber for calibration of low-energy brachytherapy sources,” Med. Phys. 20, 907(abstract) (1993).
25.J. F. Williamson, “Monte Carlo modeling of the transverse-axis dose distribution of the model 200 interstitial brachytherapy source,” Med. Phys. 27, 643–654 (2000).
26.J. F. Williamson, “The Sievert integral revisited: Evaluation and extension to and brachytherapy sources,” Int. J. Radiat. Oncol., Biol., Phys. 36, 1239–1250 (1996).
27.J. F. Williamson et al., “Guidance to users of Nycomed Amersham and North American Scientific, Inc. I-125 interstitial sources: Dosimetry and calibration changes: Recommendation of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry,” Med. Phys. 26, 570–573 (1999).
28.G. M. Daskalov and J. F. Williamson, “Monte Carlo-aided dosimetry of the new Bebig IsoSeed Interstitial Brachytherapy Seed,” Med. Phys. 28, 2154–2161 (2001).
29.R. Nath et al., Specification of Brachytherapy Source Strength: A Report by Task Group 32 of the American Association of Physicists in Medicine (American Institute of Physics, New York, 1987).
30.S. M. Seltzer et al., “New NIST air-kerma strength standards for I-125 and Pd-103 brachytherapy seeds,” presented at the AAPM Annual Meeting, San Antonio, TX, 1998 (unpublished).
31.J. F. Williamson, “The accuracy of the line and point source approximation in Ir-192 implant dosimetry,” Int. J. Radiat. Oncol., Biol., Phys. 12, 409–414 (1986).
32.J. H. Hubbell, “Review of photon interaction cross section data in the medical and biological context,” Phys. Med. Biol. 44, R1–R22 (1999).
33.R. W. Roussin et al., “Description of the DLC-99/Hugo Package of Photon Interactions,” RSIC Data Library Collection, Report No. ORNL/RSIC-46, Oak Ridge National Laboratory, Radiation Shielding Information Center, Oak Ridge, TN, 1983.
34.A. S. Kirov and J. F. Williamson, “Monte Carlo-aided dosimetry of the source tech medical model STM1251 I-125 interstitial brachytherapy source,” Med. Phys. 28, 764–772 (2001).
35.J. F. Williamson, “Recent developments in basic brachytherapy physics,” in Radiation Therapy Physics, edited by A. R. Smith (Springer, Berlin, 1995), pp. 247–302.
36.R. E. Wallace and J. J. Fan, “Report on the dosimetry of a new design brachytherapy source,” Med. Phys. 26, 1925–1931 (1999).
37.R. Nath and N. Yue, “Dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of -Model LS-1 BrachySeed™,” Appl. Radiat. Isot. 55, 813–821 (2001).
38.A. S. Meigooni, D. M. Gearheart, and K. Sowards, “Experimental determination of dosimetric characteristics of Best® brachytherapy source,” Med. Phys. 27, 2168–2173 (2000).
39.H. Hedtjärn, G. A. Carlsson, and J. F. Williamson, “Monte Carlo-aided dosimetry of the UroMed/Bebig Symmetra I-125, model I25.S06 interstitial brachytherapy seed,” Med. Phys. 27, 1076–1085 (2000).
40.P. Lindsay, J. Battista, and J. Van Dyk, “The effect of seed anisotropy on brachytherapy dose distributions using and ” Med. Phys. 28, 336–345 (2001).
41.G. M. Daskalov, M. Löffler, and J. F. Williamson, “Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source,” Med. Phys. 25, 2200–2208 (1998).
42.R. K. Das et al., “Dosimetric characteristics of the type 8 Ytterbium-169 interstitial brachytherapy source,” J. Brachytherapy Int. 13, 219–234 (1997).
43.(a) C. C. Ling et al., “Physical dosimetry of seeds of a new design for interstitial implant,” Int. J. Radiat. Oncol., Biol., Phys. 9, 1747–1752 (1983);
43.(b) B. M. Coursey (personal communication).
44.T. P. Loftus, “Exposure standardization of Iodine-125 seeds used for brachytherapy,” J. Res. Natl. Bur. Stand. 89, 295–303 (1984).
45.L. L. Anderson et al., Interstitial Brachytherapy, Physical, Biological, and Clinical Considerations (Raven, New York, 1990).
46.R. Nath, A. S. Meigooni, and J. A. Meli, “Dosimetry on transverse axes of and interstitial brachytherapy sources,” Med. Phys. 17, 1032–1040 (1990).
47.S.-T. Chiu-Tsao et al., “Dose rate determination for seeds,” Med. Phys. 17, 815–825 (1990).
48.K. A. Weaver et al., “Dose parameters of and seed sources,” Med. Phys. 16, 636–643 (1989).
49.See EPAPS Document No. for tables (AI and AII) of anisotropy functions, and a table (AIII) of dose rates in Cartesian (“away and along”) coordinates. This document may be retrieved via the EPAPS homepage (http://www.aip.org/pubservs/epaps.html) or from ftp.aip.org in the directory/epaps/. See the EPAPS homepage for more information.[Supplementary Material]
Article metrics loading...